1995
DOI: 10.1007/bf00368044
|View full text |Cite
|
Sign up to set email alerts
|

Selection of appropriate parameters, use of a quality control concept, and suitable statistical analyses for clinical pathology examination of animals in toxicity studies: Results of a current survey by the Japanese pharmaceutical manufacturers association

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

1996
1996
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 5 publications
0
8
0
Order By: Relevance
“…Similarly, the serum electrolyte levels were found to be well within the clinical range of rats which reflects that NK has no adverse effect on ionic homeostasis. Histopathological studies provide supportive evidence for biochemical and haematological observations [24]. The relative organ weights were found to be non-significant between the control and NK treated rats.…”
Section: Discussionmentioning
confidence: 64%
“…Similarly, the serum electrolyte levels were found to be well within the clinical range of rats which reflects that NK has no adverse effect on ionic homeostasis. Histopathological studies provide supportive evidence for biochemical and haematological observations [24]. The relative organ weights were found to be non-significant between the control and NK treated rats.…”
Section: Discussionmentioning
confidence: 64%
“…These changes could be regarded as tissue morphology (detected by histopathological evaluation) and/or alterations in a series of in vivo analyzed parameters. Dose-related changes were also of crucial importance [29]. Among these parameters, clinical chemistry and hematology data were of great importance for determining effects induced by treatment.…”
Section: Hematology and Clinical Chemistry Of Ccam In Vivomentioning
confidence: 99%
“…Experimental animal modelling is used to evaluate the safety of test components; any abnormal treatment‐related values represent changes relevant to its pharmacological or toxicological effects thus must be documented through serum biochemical evaluation (Matsuzawa et al. , 1995).…”
Section: Introductionmentioning
confidence: 99%